Ma H - Search Results

1

Gold Nanoclusters-Based NIR-II Photosensitizers with Catalase-like Activity for Boosted Photodynamic Therapy.

Dan Q, Yuan Z, Zheng S, Ma H, Luo W, Zhang L, Su N, Hu D, Sheng Z, Li Y. Dan Q, et al. Among authors: ma h. Pharmaceutics. 2022 Aug 7;14(8):1645. doi: 10.3390/pharmaceutics14081645. Pharmaceutics. 2022. PMID: 36015272 Free PMC article.

2

Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study.

Zhu L, Zeng X, Jiang S, Ruan S, Ma H, Li Y, Ye C, Dong J. Zhu L, et al. Among authors: ma h. BMJ Open. 2022 Jun 27;12(6):e057080. doi: 10.1136/bmjopen-2021-057080. BMJ Open. 2022. PMID: 35760543 Free PMC article.

3

Covalent organic framework based cytoprotective therapy after ischemic stroke.

Peng Y, Ren Q, Ma H, Lin C, Yu M, Li Y, Chen J, Xu H, Zhao P, Pan S, Tao J, Huang K. Peng Y, et al. Among authors: ma h. Redox Biol. 2024 May;71:103106. doi: 10.1016/j.redox.2024.103106. Epub 2024 Feb 28. Redox Biol. 2024. PMID: 38442647 Free PMC article.

4

Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer.

Ma H, Wu J, Zhou M, Wu J, Wu Z, Lin L, Huang N, Liao W, Sun L. Ma H, et al. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211045349. doi: 10.1177/15347354211045349. Integr Cancer Ther. 2021. PMID: 34590499 Free PMC article.

5

Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cells.

Li Y, Huang N, Wang C, Ma H, Zhou M, Lin L, Huang Z, Sun L, Shi M, Liao W. Li Y, et al. Among authors: ma h. Oncol Lett. 2018 Sep;16(3):2839-2850. doi: 10.3892/ol.2018.9019. Epub 2018 Jun 25. Oncol Lett. 2018. PMID: 30127870 Free PMC article.

6

MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling.

Huang N, Wu Z, Lin L, Zhou M, Wang L, Ma H, Xia J, Bin J, Liao Y, Liao W. Huang N, et al. Among authors: ma h. Oncotarget. 2015 Jun 20;6(17):15222-34. doi: 10.18632/oncotarget.3835. Oncotarget. 2015. PMID: 25945841 Free PMC article.

7

IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.

Xu L, Zhou R, Yuan L, Wang S, Li X, Ma H, Zhou M, Pan C, Zhang J, Huang N, Shi M, Bin J, Liao Y, Liao W. Xu L, et al. Among authors: ma h. Cancer Lett. 2017 May 1;393:76-85. doi: 10.1016/j.canlet.2017.02.014. Epub 2017 Feb 20. Cancer Lett. 2017. PMID: 28223169

8

Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.

Ma H, Wu Z, Peng J, Li Y, Huang H, Liao Y, Zhou M, Sun L, Huang N, Shi M, Bin J, Liao Y, Rao J, Wang L, Liao W. Ma H, et al. Int J Cancer. 2018 Jun 15;142(12):2578-2588. doi: 10.1002/ijc.31274. Epub 2018 Feb 9. Int J Cancer. 2018. PMID: 29363109

9

Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.

Ma H, Liu Y, Shi M, Shao X, Zhong W, Liao W, Xing MM. Ma H, et al. Biomacromolecules. 2015 Dec 14;16(12):4022-31. doi: 10.1021/acs.biomac.5b01039. Epub 2015 Nov 16. Biomacromolecules. 2015. PMID: 26477267

10

Defect Chemistry Engineering to Regulate the Excellent ZT_ave Value of Nonstoichiometric Ca_3-xCo₄O₉ (0 ≤ x ≤ 0.06) Ceramics.

Han Z, Zhang J, Ma H, Xing F, Qi Y, Wei J, He G, Zhang Y, Xin Y, Wang Q, Shi Z. Han Z, et al. Among authors: ma h. ACS Appl Mater Interfaces. 2025 Jan 10. doi: 10.1021/acsami.4c19212. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39791863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,130 results

Search Page

Filters